Wow, the company released a PR but yet again it's just a recap of what we already know. It's not the PR we want. The FDA is very specific in what it needs. I surely hope BMSN has people who know how to submit INDs properly. Two rounds of questions for an IND might be normal but we don't know if the questions were based on incomplete info. Let's hope BMSN finally gets the answer it needs and the answer we want. Another round of of Q & A could possibly knock this stock down another .001 cents or more.